Decision Analysis Model Comparing Cost of IsoPSA&#8482; vs Repeat Biopsy for Detection of Clinically Significant Prostate Cancer in Men with Previous Negative Findings on Biopsy.

Lotan, Yair; Stovsky, Mark; Rochelle, Robert; Klein, Eric

Decision Analysis Model Comparing Cost of IsoPSA™ vs Repeat Biopsy for Detection of Clinically Significant Prostate Cancer in Men with Previous Negative Findings on Biopsy.

Lotan, Yair; Stovsky, Mark; Rochelle, Robert; Klein, Eric.

Lotan Y; Department of Urology, UT Southwestern Medical Center, Dallas, Texas.
Stovsky M; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
Rochelle R; Cleveland Diagnostics, Inc., Cleveland, Ohio.
Klein E; Cleveland Diagnostics, Inc., Cleveland, Ohio.

Urol Pract ; 8(1): 40-46, 2021 Jan.

Article en En | MEDLINE | ID: mdl-37145424

Palabras clave

biopsy; cost-benefit analysis; high-intensity focused; prostate-specific antigen; prostatic neoplasms; transrectal; ultrasound

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Health_economic_evaluation / Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google